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a  b  s  t  r  a  c  t
Objective: To present epidemiological data and risk factors associated with surgical out-
comes  favorable or unfavorable for the treatment of infection in infected total knee
arthroplasty.
Methods:  We  reviewed medical records of 48 patients who underwent treatment of pri-
mary  total knee arthroplasty for infection between January 1994 and December 2008, in
the  Orthopedics and Traumatology Department of the Santa Casa de Misericórdia de São
Paulo.  The variables associated with favorable outcome of surgical treatment (debridement
and  retention or exchange arthroplasty in two days) or unfavorable (arthrodesis or death)
infection.
Results:  A total of 39 cases of infection after primary total knee arthroplasty, 22 progressed
to  17 for a favorable outcome and unfavorable outcome. Early infections (OR: 14.0, 95% CI
1.5–133.2, p = 0.016) and diabetes (OR: 11.3, 95% CI 1.4–89.3, p = 0.032) were associated with
arthrodesis  joint and death respectively.
Conclusion: Patients with early infection had a higher risk of developing surgical proce-
dure  with unfavorable outcome (arthrodesis) and diabetics had higher odds of death afterinfection  of primary knee arthroplasties.
© 2013 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. 
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r  e  s  u  m  o
Objetivo: Apresentar dados epidemiológicos e os fatores de risco associados ao desfecho
cirúrgico favorável ou desfavorável para o tratamento da infecc¸ão  na artroplastia total de
joelho infectada.
Metódos: Foram revisados 48 prontuários de pacientes submetidos ao tratamento da artro-
plastia total primária de joelho por infecc¸ão  entre janeiro de 1994 e dezembro de 2008 no
Servic¸o  de Ortopedia e Traumatologia da Santa Casa de Misericórdia de São Paulo. Foram
analisadas as variáveis associadas ao desfecho do tratamento cirúrgico favorável (desbrida-
mento e retenc¸ão  da artroplastia ou troca em dois tempos) ou desfavorável (artrodeses ou
óbito) da infecc¸ão.
Resultados: Em 39 casos de infecc¸ão  pós-artroplastia total primária no joelho, 22 evoluíram
para desfecho favorável e 17 para desfecho desfavorável. Infecc¸ões  precoces (RC: 14,0,
IC95% 1,5–133,2, p = 0,016) e diabetes (RC: 11,3, IC95% 1,4–89,3, p = 0,032) foram associadas a
artrodese da articulac¸ão  e ao óbito, respectivamente.
Conclusão: Pacientes com infecc¸ão  precoce apresentaram maior risco de evoluir para pro-
cedimento cirúrgico com desfecho não favorável (artrodese) e os diabéticos apresentaram
maior chance de óbito após infecc¸ão  de artroplastias primárias no joelho.
































steoarthrosis is the most prevalent joint disease among
lderly  adults and it occurs because of the joint car-
ilage degeneration process. Knee arthroplasty is a
urgical  technique for treating advanced osteoarthro-
is and is being increasingly used because of its good
esults regarding pain relief and reestablishment of
unction. Like all surgical procedures, total knee arthro-
lasty  (TKA) is subject to complications over the short or
ong  term, including the following: systemic and throm-
oembolic phenomena; complications that affect the
atellofemoral joint; neurovascular lesions; periprosthetic
ractures; loosening of the implanted components; and
nfection.1
Among all the complications, post-arthroplasty infection is
ne of the most severe and feared types and its incidence may
ange  from 0.5 to 23%.2,3 Post-arthroplasty knee infections
ave an economic impact greater than 300 million dollars per
ear  in the countries of North America.4
For treatment of infected TKA to be successful,
arly diagnosis is fundamental, with immediate appli-
ation  of therapeutic measures. Appropriate physical
xamination, imaging examinations, laboratory tests
o  investigate inﬂammatory activity and puncturing of
he  affected knee may  assist greatly in deﬁning the best
anagement.4
Regarding the treatment for the infection, several types
f  surgical procedure have been described, including the
ollowing:  surgical cleaning with retention of the implant;
evision in a one-stage procedure, consisting of removal
f  the implant, rigorous surgical cleaning and placement
f  a new prosthesis; revision in two stages, in which
mplanting the new prosthesis is postponed until a timeEditora  Ltda. 
that  some authors consider to be safer; and salvage pro-
cedures  such as arthrodesis and amputation, in cases of
lack  of success in previous attempts.5 All these procedures
should be accompanied by appropriate antibiotic therapy
according to the pathogens identiﬁed as responsible for the
infection.6
The gold standard for treating cases of infected TKA
when implant removal becomes necessary is two-stage revi-
sion.  In this, intravenous antibiotics are administered for
six  weeks after debridement and then ﬁlling the joint cav-
ity  with a spacer comprising orthopedic cement with added
antibiotic.7 The aims in applying the spacer are to main-
tain  the joint distances, occupy the empty spaces between
the  structures and release high levels of antibiotic at this
site.8 The second stage is performed taking into consid-
eration the possibility of curing the infection,7 which is
conﬁrmed through clinical reassessment and producing a
hemogram  comprising a leukocyte count and inﬂammatory
marker tests such as the erythrocyte sedimentation rate
and  C-reactive protein level, and joint puncture in order
to  culture the synovial ﬂuid.5 When the results from the
examinations are within the range of normality and the cul-
tures  are negative, the patient then undergoes the revision,
which  consists removal of the spacer and placement of a
new  joint implant that is ﬁxed using cement with added
antibiotic.5,7
Even though this is a catastrophic complication for TKA
patients,  with high costs for the healthcare system, few stud-
ies  have evaluated the factors associated with failure of the
surgical  methods that are used for curing infected knee arthro-
plasty  cases.9
Este é um artigo Open Access sob a licença de CC BY-NC-NDThe aim of this study was to make a descriptive analysis
of  infected TKA cases and the possible risk factors associated
with  unfavorable outcomes following surgical therapy for the
infection.
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patients  presented early infection (48.72%), eight had inter-
mediate  infection (20.52%) and 12 had late infection (30.76%).434  r e v b r a s o r t o 
Methodology
This was  a retrospective case–control study conducted by the
Knee  Surgery Group of the Department of Orthopedics and
Traumatology, Santa Casa de Misericórdia de São Paulo. The
population  for this study consisted of all the individuals who
underwent  primary TKA between January 1994 and Decem-
ber  2008, who  were  identiﬁed by means of the database of
the  institution’s Knee Group. Among these, only the patients
who  presented signs and symptoms of infection subsequent
to  primary TKA were  analyzed through reviewing the medical
records.  This study was  approved by the institution’s Research
Ethics  Committee.
Infections in revision knee arthroplasty procedures and
infections  conﬁrmed by means of a swab from secretions from
the  operative wound and/or cases for which insufﬁcient infor-
mation  was  available in the medical records were  excluded.
The  diagnostic criteria for infection associated with arthro-
plasty  were  established in accordance with a previously
published study.10 The microbiological conﬁrmation of the
infection  was  done by means of culturing two or more tissue
samples  from the periprosthetic region, and from bone tissue
and  identiﬁcation of the pathogen in the synovial ﬂuid, along
with  the histopathological description.11
All the patients underwent arthrotomy, implant removal,
placement of a cemented spacer (PMMA) incorporating van-
comycin,  provisional immobilization using a splint and use
of  an orthosis or external ﬁxation, given the great instabil-
ity  of the region. The stabilization method was  selected by
the  same surgeon, according to the stability that had been
acquired  through placement of the spacer.
Among the variables studied, parameters relating to the
patients  were  evaluated, such as: sex, age, comorbidities
(obesity, HIV, previous use of corticoids, diabetes mellitus,
arterial  hypertension, rheumatoid arthritis and smoking) and
the  diagnosis that indicated the need for TKA. In relation
to  the infection, the following data were  gathered: the time
that  elapsed between the surgery and the diagnosis of infec-
tion  (up to three months after the surgery was  considered
to  be early infection, from three to 24 months was  con-
sidered  to be intermediate infection and 24 months was
considered to be late infection)12 and the bacteria that were
isolated  from the cultures, which were  differentiated between
polymicrobial infection (two or more  pathogens identiﬁed in
cultures) and monobacterial infection. The surgical therapy
was  characterized as revision arthroplasty (surgical debride-
ment  with retention of the prosthesis and two-stage revision
of  an infected prosthesis) or salvage procedures (arthrodesis
or  amputation).
Statistical  analysis
The descriptive analysis on all the characteristics studied
was  done using percentages for the qualitative variables and
means  and standard deviations for the quantitative variables.
To  analyze the associations between the risk factors and the
success  of the surgical therapy, we  characterized the outcome
variable  as functional surgical treatment (F) when the cure for1 3;4 8(5):432–437
the infection was  associated with debridement and retention
of  the prosthesis, or with conventional revision arthroplasty or
use of an unconventional endoprosthesis; or as nonfunctional
surgical treatment (NF) when the cure for the infection was
associated  with joint arthrodesis or death associated with the
infection.  In addition, we analyzed the risk factors associated
with  infection-related death. For bivariate analyses, Fisher’s
exact  test was  used, with the statistical signiﬁcance level of
p  < 0.05 and a 95% conﬁdence interval. All the analyses were
done  using the R statistical software, version 2.15.0.1
Results
Out of the 592 patients who underwent primary TKA in the
Department  of Orthopedics, Santa Casa de Misericórdia de
São  Paulo, 38 (6.42%) evolved with infection. In addition, ten
patients  who were  included in the sample came from other
medical  institutions and were referred for treatment at Santa
Casa  de Misericórdia de São Paulo. Thus, the total sample eval-
uated  in this study was 48 cases of infected TKA. Nine patients
(18.75%)  were  excluded from the analysis because of difﬁculty
in  identifying the variables in the medical ﬁles.
Among the 39 patients studied, 34 (87.18%) were  female and
ﬁve  (12.82%) were  male. The age range was from 41 to 89 years,
with  a mean of 69.7 years (SD ± 10.0 years). The mean length
of  time between the surgery and the diagnosing of infection
was  70.4 weeks (SD ± 15.3). The right knee was affected in 20
patients  (51.28%) and the left knee in 19 (48.72%).
The disease that led to the indication of arthroplasty was
primary  knee arthrosis in 29 patients (74.35%) and the cases
of  secondary knee arthrosis were consequent to the follow-
ing:  rheumatoid arthritis in two (5.12%), aseptic osteonecrosis
of  the femur due to corticoid use in two (5.12%), sequelae
of  septic arthritis in one (2.56%), synovial chondromatosis in
one (2.56%), ligament injury in one (2.56%) and post-fracture
sequelae in the knee region (including the distal femur and
proximal  tibia, which affect the joint area) in three (7.68%).
The  infectious agents identiﬁed were: Staphylococcus aureus
(31.2%);  Pseudomonas aeruginosa (22.9%), coagulase-negative
Staphylococcus (14.5%), Enterococcus sp (2.1%), Enterobacter
(10.4%), Streptococcus pyogenes (8.3%), Escherichia coli (4.1%), Pro-
teus mirabilis (2.1%), Stenotrophomonas maltophilia (2.1%) and
Corynebacterium sp (2.1%) (Table 1). Seven infections were
polymicrobial (17.94%) and 32 were monomicrobial (82.06%).
Regarding  the presence of comorbidities, 31 patients
(79.48%) presented systemic arterial hypertension and nine
(23.07%)  presented diabetes (types I or II). Diabetes and arte-
rial  hypertension occurred in association in eight patients
(20.51%); two (5.12%) said that they were smokers; and two
(5.12%)  presented rheumatoid arthritis. Five patients (12.82%)
did  not have any comorbidities (Table 2).
According to the time that had elapsed from the surgery
to  the appearance of signs and symptoms of infection, 191 www.r-project.org.
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Table 1 – Pathogens identiﬁed in intraoperative issue
cultures.
Types of cultures identiﬁed N %
Staphylococcus aureus 15 31.25
Pseudomonas aeruginosa 11 22.92
Coagulase-negative Staphylococcus 7 14.58
Enterobacter sp. 5 10.41
Streptococcus pyogenes 4 8.33
Escherichia coli 2 4.16
Corynebacterium sp. 1  2.1
Stenotrophomonas maltophilia 1  2.1





















1Proteus mirabilis 1 2.1
Total 48 100.0
In relation to therapy for the infected arthroplasty cases,
 revision prosthesis implanted in two stages was  used in
0  patients (51.3%), a nonconventional endoprosthesis in one
2.6%),  arthrodesis in 12 (30.7%) and chronic suppression
ntibiotic therapy in one (2.6%). Infection-associated death
ccurred  in the cases of ﬁve patients (12.8%).
In relation to the analysis on risk factors associated with
he  therapeutic outcome, i.e. failure (NF) or success (F) of the
urgical  procedure associated with the cure for the infection
n  the primary TKA, we observed that variables such as age,
ex,  presence of primary or secondary arthrosis, identiﬁca-
ion  of bacteria in cultures, monomicrobial or polymicrobial
nfections, presence or absence of Staphylococcus aureus, iden-
iﬁcation  of pathogens in more  than one tissue sample and
resence  of comorbidities did not demonstrate any statis-
ically  signiﬁcant association with the outcomes described.
owever, in the cases of infection diagnosed up to three
onths after the surgery (early period), there was  a sta-
istically  signiﬁcant association with nonfunctional surgical
reatment  (NF) (OR: 14.0; 95% CI: 1.5–133.2; p = 0.016) (Table 3).
Analysis on the variables associated with death secondary
o  infection showed that only the patients with diabetes mel-
itus  had a statistically signiﬁcant association with death (OR:
1.3;  95% CI: 1.4–89.3; p = 0.032).
Table 2 – Distribution of types of comorbidities
presented by patients (some of them presented more
than  one type of comorbidity).
Types of comorbidity N %
Arterial hypertension 31 54.4
Diabetes 9 15.8




Corticoid use 1 1.8
Alcohol abuse 1 1.8
Liver disease 1 1.8
Heart failure 1 1.8
Obesity 1 1.8
Liver transplantation 1 1.8
Total 55 100.0;4 8(5):432–437  435
Discussion
It is now known that the number of total arthroplasty proce-
dures  performed has been increasing rapidly year by year. It
has  been estimated that between 2005 and 2030, the number of
TKA  procedures performed in the United States is expected to
increase by up to 673% and reach the level of 3.48 million pro-
cedures  per year.6,13 Improvement of the operative techniques
and  asepsis procedures, and use of preoperative antibiotics,
has  reduced the risk of infection in primary prostheses.14,15
However, even with these changes, the increase in the num-
ber  of procedures has generated ever-greater numbers of cases
of  infection that require surgical treatment.15 The infection
rates  in previous studies ranged from 1% to 5% for infections
in  primary arthroplasty cases.16 At Santa Casa de Misericórdia
de  São Paulo, which is teaching hospital that attends patients
within  the Brazilian National Health System (SUS), the infec-
tion  rate after primary knee arthroplasty was assessed as 6.4%
over  the period from 1994 to 2008. This ﬁgure probably reﬂects
surgical  treatments for patients with comorbidities such as
diabetes  mellitus, infections of greater severity (such as those
that  occur during the early period, i.e. up to three months after
the  surgery) and polymicrobial infection caused by pathogens
presenting greater bacterial resistance. Ong et al.17 evalu-
ated  the risk factors for infection in a cohort consisting of
a  large number of individuals who underwent primary hip
arthroplasty and concluded that in operations performed in
medical institutions with public attendance (Medicare), pres-
ence  of comorbidities, male sex and prolonged duration of
surgery  inﬂuenced the infection rates.
Among the patients with a diagnosis of early infection, it
was  observed that the risk of a nonfunctional surgical outcome
from  treating infections was  14 times greater than in the cases
of  intermediate and late infection. The diabetics presented a
higher risk of death, possibly associated with the complexity
and  extent of the infection. Laffer et al.18 demonstrated that
patients  with infected knee arthroplasty diagnosed during the
intermediate  phase presented a higher rate of unfavorable
outcomes, probably because of late diagnosis of the infection.
Although without statistical signiﬁcance, possibly related
to  the small number of infected individuals in the ﬁnal sample,
the  patients of more  advanced age and male sex with diabetes
presented  greater risk of nonfunctional evolution in the sur-
gical  treatment. Infections caused by Staphylococcus aureus in
individuals with secondary arthrosis presented greater risk of
death.  Galat et al.9 analyzed the risk factors for early complica-
tions  of the operative wound in more  than 17,000 individuals
who  underwent primary TKA and found that the presence
of  diabetes mellitus had a statistically signiﬁcant associa-
tion  with the risk of infection. Infections in knee arthroplasty
cases caused by S. aureus, and particularly oxacillin-resistant S.
aureus, has already been correlated with unfavorable evolution
in  other published papers.19
The mean age of the patients evaluated was  69.4 years
and  among those of advanced age (over 80 years), there
was  a nonsigniﬁcant association with nonfunctional evolution
from  surgical therapy, possibly related to the small sample
size  (odds ratio = 2.2). In a retrospective cohort of infected
arthroplasty cases that were treated with debridement and
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Table 3 – Risk factors associated with therapeutic failure or success in treating infected total knee arthroplasty cases.
Characteristics Result Total p-Valuea Odds ratio
Therapeutic
success  N = 22
(%)
Therapeutic
failure  N = 17
(%)
N  = 39 (%) Estimate 95% CIc
Age
41–59 years 3 (60.0) 2 (40.00) 5 12.8 0.927 (ref)b
60–69 years 7 (58.33) 5 (41.67) 12 30.8 1.1 0.1 – 9
70–79 years 10 (58.82) 7 (41.18) 17 43.6 1 0.1 – 8
80–89 years 2 (40.0) 3 (60.00) 5 12.8 2.2 0.2 – 28.3
Sex
Female 20 (60.60) 13 (39.40) 33 84.6 0.374 (ref)b
Male 2 (33.33) 4 (66.67) 6 15.4 3.1 0.5 – 19.3
Diagnosis
Primary 15 (51.72) 14 (48.28) 29 74.4 0.464 (ref)b
Secondary 7 (70.0) 3 (30.0) 10 25.6 0.5 0.1 – 2.1
Time
Early 8 (36.36) 14 (63.64) 22 56.4 0.016* 14 1.5 – 133.2
Intermediate 8 (88.89) 1 (11.11) 9 23.1 (ref)b
Late 6 (75.00) 2 (25.00) 8 20.5 2.7 0.2 – 36.8
Number of comorbidities
0  3 (50.00) 3 (50.00) 6 15.4 0.738 (ref)b
1 14 (60.87) 9 (39.13) 23 59 0.6 0.1 – 3.9
2 or more 5 (50.00) 5 (50.00) 10 25.6 1 0.1 – 7.6
Hypertension
No 5 (62.5) 3 (37.5) 8 20.5 1 (ref)b
Yes 17 (54.83) 14 (45.17) 31 79.5 1.4 0.3 – 6.8
Diabetic
No 20 (62.5) 12 (37.5) 32 82.1 0.206 (ref)b
Yes 2 (28.57) 5 (71.43) 7 18 4.2 0.7 – 24.9
Total 22 (56.41) 17 (43.59) 39 100
a Result from Fisher’s exact test.
b Reference group.
c 95% conﬁdence interval.
∗ 5% signiﬁcance level (p-value p < 0.05).
maintenance of the prosthesis, the mean age was also high
(74  years).20
Out of the 39 patients evaluated in our study, 56.4%
presented early infection. Intermediate and late infections
occurred in 23.1% and 20.5%, respectively. Early infections
generally result from perioperative contamination caused by
pathogenic agents such as Staphylococcus aureus or Gram-
negative bacilli, which produce acute manifestations such as
local pain, erythema, edema and heat in the operative wound,
infected  hematomas and fever. Late infections may  begin with
symptoms  of sepsis and generally result from hematogenic
dissemination of distant foci.6,12,21,22
Staphylococcus sp. was  identiﬁed in 45% of the cases, and
Staphylococcus aureus in 32%. Byren et al.19 evaluated infections
subsequent to arthroplasty procedures and found Staphylococ-
cus  aureus in 42% of the cases. Marculescu et al.20 diagnosed an
infection rate due to Staphylococcus aureus of 32%, i.e. a ﬁgure
similar  to what we  found.
In our sample, 12.8% evolved to death, which was a
high  number in comparison with Carvalho Junior et al.,23
who  found a death rate of 2.5% out of 120 primary
knee arthroplasty cases. However, Morrey et al.24 found adeath rate of 7% out of 501 unilateral knee arthroplasty
cases.
Among our patients, 37% evolved to salvage surgical pro-
cedures  (nonfunctional), which was  a higher number with
this  outcome than found by D’Elia et al.,25 who found that
only  6.9% of their patients showed this, between 2003 and
2004.  It is important to emphasize that revision arthroplasty
to  treat infections was  not so commonly performed in our
institution  in the 1990s, which resulted in a larger number
of  arthrodesis procedures in the past. From 1994 to 2001, 20
cases  were evaluated due to infection. Of these, eight (40%)
underwent arthrodesis. On the other hand, from 2002 to 2008,
there  were 19 cases, of which four (21%) underwent arthrode-
sis.
ConclusionPatients with early infection presented greater risk of evolv-
ing  toward surgical procedures with nonfunctional outcomes
(arthrodesis) and diabetics presented a greater chance of death
after  infection of primary TKA.
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